DK159427C - Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf - Google Patents
Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte derafInfo
- Publication number
- DK159427C DK159427C DK130382A DK130382A DK159427C DK 159427 C DK159427 C DK 159427C DK 130382 A DK130382 A DK 130382A DK 130382 A DK130382 A DK 130382A DK 159427 C DK159427 C DK 159427C
- Authority
- DK
- Denmark
- Prior art keywords
- quinolinon
- derivatives
- salts
- preparation
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH198681 | 1981-03-24 | ||
| CH198681 | 1981-03-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK130382A DK130382A (da) | 1982-09-25 |
| DK159427B DK159427B (da) | 1990-10-15 |
| DK159427C true DK159427C (da) | 1991-03-18 |
Family
ID=4223231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK130382A DK159427C (da) | 1981-03-24 | 1982-03-23 | Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4476132A (da) |
| EP (1) | EP0062001B1 (da) |
| JP (1) | JPH066576B2 (da) |
| AR (4) | AR242189A1 (da) |
| AT (1) | ATE27451T1 (da) |
| AU (1) | AU560003B2 (da) |
| CY (1) | CY1412A (da) |
| DE (1) | DE3276432D1 (da) |
| DK (1) | DK159427C (da) |
| ES (7) | ES510685A0 (da) |
| FI (1) | FI77853C (da) |
| GB (1) | GB2095668B (da) |
| GR (1) | GR78345B (da) |
| HK (1) | HK3988A (da) |
| HU (1) | HU192103B (da) |
| IE (1) | IE53158B1 (da) |
| IL (1) | IL65327A0 (da) |
| MY (1) | MY8700806A (da) |
| NO (1) | NO160074C (da) |
| NZ (1) | NZ200106A (da) |
| PT (1) | PT74634B (da) |
| ZA (1) | ZA821957B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58219166A (ja) * | 1982-06-14 | 1983-12-20 | Nippon Shinyaku Co Ltd | ４−キノロン誘導体 |
| JPS58225065A (ja) * | 1982-06-21 | 1983-12-27 | Nippon Shinyaku Co Ltd | ２−キノロン誘導体 |
| US4675432A (en) * | 1986-08-29 | 1987-06-23 | American Cyanamid Company | Method for the preparation of anilinofumarate |
| US6034100A (en) * | 1993-03-10 | 2000-03-07 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting cytokine secretion |
| BR0114253A (pt) * | 2000-10-02 | 2003-07-01 | Janssen Pharmaceutica Nv | Antagonistas de receptor de glutamato metabotrópico |
| EA009334B1 (ru) * | 2002-03-29 | 2007-12-28 | Янссен Фармацевтика Н.В. | Меченные радиоактивными изотопами производные хинолина и их применение в качестве лигандов метаботропного глутаматного рецептора |
| ES2628365T3 (es) | 2012-10-16 | 2017-08-02 | Janssen Pharmaceutica N.V. | Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T |
| MX358508B (es) | 2012-10-16 | 2018-08-22 | Janssen Pharmaceutica Nv | Moduladores de quinolinilo unidos a metileno de receptor nuclear de acido retinoico-gamma-t. |
| US9303015B2 (en) | 2012-10-16 | 2016-04-05 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORγt |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| CA2927182A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | Quinolinyl modulators of ror.gamma.t |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| EP3057421B1 (en) | 2013-10-15 | 2019-11-20 | Janssen Pharmaceutica NV | Alkyl linked quinolinyl modulators of ror(gamma)t |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB830832A (en) * | 1957-02-15 | 1960-03-23 | Ici Ltd | New quinolones and therapeutic compositions containing them |
| GB1013224A (en) * | 1962-06-21 | 1965-12-15 | Ici Ltd | Heterocyclic aminoethanols |
| CH529136A (de) * | 1966-09-29 | 1972-10-15 | Ciba Geigy Ag | Verfahren zur Herstellung von heterocyclischen Carbonsäuren |
| US3496184A (en) * | 1969-03-18 | 1970-02-17 | Ciba Geigy Corp | Cyclopropylmethoxy-3-quinoline carboxylic acids and esters |
| NL7101049A (da) * | 1970-01-28 | 1971-07-30 | ||
| GB1334705A (en) * | 1970-06-19 | 1973-10-24 | Ici Ltd | Pharmaceutical compositions containing kynurenic acid derivatives |
| CA942748A (en) * | 1970-09-18 | 1974-02-26 | Venkatachala L. Narayanan | 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds |
| US4190659A (en) * | 1973-08-27 | 1980-02-26 | Sandoz, Inc. | Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters |
| US4086349A (en) * | 1975-07-30 | 1978-04-25 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Quinolopyran-4-one-2-carboxylic acid derivatives and salts thereof as novel compounds and as medicines for treatment of allergic asthma |
| JPS609511B2 (ja) * | 1976-07-16 | 1985-03-11 | 大塚製薬株式会社 | ５−カルボスチリルメタノ−ル誘導体 |
| JPS609713B2 (ja) * | 1976-10-08 | 1985-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体 |
| US4186201A (en) * | 1977-02-07 | 1980-01-29 | Riker Laboratories, Inc. | Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds |
| US4187309A (en) * | 1977-06-20 | 1980-02-05 | Sandoz, Inc. | 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof |
| US4119720A (en) * | 1977-07-06 | 1978-10-10 | Sandoz, Inc. | Unsaturated esters of 4-hydroxy-2-quinolinone-3-carboxylic acids and salts thereof |
| DE2806879A1 (de) * | 1978-02-17 | 1979-08-23 | Sandoz Ag | 4-hydroxy-2-chinolinon-3-carbonsaeure- esterderivate |
-
1982
- 1982-03-18 EP EP82810126A patent/EP0062001B1/de not_active Expired
- 1982-03-18 AT AT82810126T patent/ATE27451T1/de not_active IP Right Cessation
- 1982-03-18 DE DE8282810126T patent/DE3276432D1/de not_active Expired
- 1982-03-19 US US06/360,016 patent/US4476132A/en not_active Expired - Lifetime
- 1982-03-22 GR GR67672A patent/GR78345B/el unknown
- 1982-03-22 FI FI820983A patent/FI77853C/fi not_active IP Right Cessation
- 1982-03-22 PT PT74634A patent/PT74634B/pt not_active IP Right Cessation
- 1982-03-23 HU HU82881A patent/HU192103B/hu not_active IP Right Cessation
- 1982-03-23 IE IE670/82A patent/IE53158B1/en not_active IP Right Cessation
- 1982-03-23 NZ NZ200106A patent/NZ200106A/en unknown
- 1982-03-23 AU AU81819/82A patent/AU560003B2/en not_active Ceased
- 1982-03-23 GB GB8208394A patent/GB2095668B/en not_active Expired
- 1982-03-23 DK DK130382A patent/DK159427C/da not_active IP Right Cessation
- 1982-03-23 ES ES510685A patent/ES510685A0/es active Granted
- 1982-03-23 ZA ZA821957A patent/ZA821957B/xx unknown
- 1982-03-23 NO NO820959A patent/NO160074C/no unknown
- 1982-03-23 CY CY141282A patent/CY1412A/xx unknown
- 1982-03-23 IL IL65327A patent/IL65327A0/xx not_active IP Right Cessation
- 1982-03-24 AR AR82288857A patent/AR242189A1/es active
- 1982-03-24 JP JP57045754A patent/JPH066576B2/ja not_active Expired - Lifetime
-
1983
- 1983-06-16 ES ES523338A patent/ES8503662A1/es not_active Expired
- 1983-06-16 ES ES523342A patent/ES8503665A1/es not_active Expired
- 1983-06-16 ES ES523337A patent/ES8503661A1/es not_active Expired
- 1983-06-16 ES ES523341A patent/ES523341A0/es active Granted
- 1983-06-16 ES ES523340A patent/ES8503664A1/es not_active Expired
- 1983-06-16 ES ES523339A patent/ES523339A0/es active Granted
- 1983-11-30 AR AR83294975A patent/AR242376A1/es active
- 1983-11-30 AR AR29497383A patent/AR240739A1/es active
- 1983-11-30 AR AR294972A patent/AR240044A1/es active
-
1987
- 1987-12-30 MY MY806/87A patent/MY8700806A/xx unknown
-
1988
- 1988-01-14 HK HK39/88A patent/HK3988A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK146482A (da) | Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf | |
| DK127982A (da) | Fremgangsmaade til fremstilling af flercycliske forbindelser eller salte,estre eller amider deraf | |
| DK28282A (da) | Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf | |
| DK148260C (da) | Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf | |
| DK160561C (da) | Analogifremgangsmaade til fremstilling af 3-aminopregn-5-enderivater eller salte deraf | |
| DK503080A (da) | Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf | |
| DK159427C (da) | Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf | |
| DK162991C (da) | Analogifremgangsmaade til fremstilling af thiazolidinylalkylenpiperazinderivater | |
| DK273479A (da) | Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf | |
| DK493083A (da) | Fremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf | |
| DK70083D0 (da) | Fremgangsmade til fremstilling af pyrroleddikesyreamider eller salte deraf | |
| DK69382A (da) | Fremgangsmaade til fremstilling af azepinderivater eller saltederaf | |
| DK324979A (da) | Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf | |
| DK223177A (da) | Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf | |
| DK438482A (da) | Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf | |
| DK147623C (da) | Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf | |
| DK158227C (da) | Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf | |
| DK115379A (da) | Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf | |
| DK224381A (da) | Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf | |
| DK149823C (da) | Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf | |
| DK476082A (da) | Fremgangsmaade til fremstilling af phenolderivater eller salte deraf | |
| DK432582A (da) | Fremgangsmaade til fremstilling af aminooxazolylforbindelser eller salte deraf | |
| DK186283D0 (da) | Fremgangsmade til fremstilling af imidazoquinoxaliner eller salte deraf | |
| DK205082A (da) | Fremgangsmaade til fremstilling af substituerede 2-aminoethanoler eller salte deraf | |
| DK226883A (da) | Fremgangsmaade til fremstilling af trialkylsiliciumholdige phenylcycloalkan-forbindelser eller farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment | ||
| PBP | Patent lapsed |